1. Home
  2. Pharma & Healthcare
  3. Global Antivenom Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Antivenom Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 132 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Antivenom market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Antivenom market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Antivenom in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Polyvalent antivenom
Monovalent antivenom

Market Snapshot, By Application
Non-profit Institutions
Hospitals and Clinic

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
CSL
Vins Bioproducts
Serum Biotech
Rare Disease Therapeutics
Pfizer
MicroPharm
Merck
Haffkine Bio-Pharmaceutical
Flynn Pharma
BTG
Bharat Serums and Vaccines

The study objectives of this report are:
To study and analyze the global Antivenom market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Antivenom market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Antivenom manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antivenom market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Antivenom submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antivenom are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Antivenom Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Antivenom Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Antivenom

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Antivenom Sales Channel and Distributors Analysis
3.3.1 Antivenom Sales Channel
3.3.2 Antivenom Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Antivenom Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Antivenom Type Introduction
4.1.1 Polyvalent antivenom
4.1.2 Monovalent antivenom
4.2 Global Antivenom Sales by Type 2016-2021
4.3 Global Antivenom Revenue by Type 2016-2021
4.4 Global Antivenom Price by Type 2016-2021

5 Market Segment: by Application
5.1 Antivenom Type Introduction
5.1.1 Non-profit Institutions
5.1.2 Hospitals and Clinic
5.2 Global Antivenom Sales by Application 2016-2021
5.3 Global Antivenom Revenue by Application 2016-2021
5.4 Global Antivenom Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Antivenom Market by Region
6.1.1 Global Antivenom Sales by Regions
6.1.2 Global Antivenom Revenue by Regions
6.2 North America Antivenom Market 2016-2021
6.3 Europe Antivenom Market 2016-2021
6.4 Asia Pacific Antivenom Market 2016-2021
6.5 South America Antivenom Market 2016-2021
6.6 Middle East and Africa Antivenom Market 2016-2021

7 North America
7.1 North America Antivenom Market by Country 2016-2021
7.1.1 North America Antivenom Sales by Country
7.1.2 North America Antivenom Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Antivenom Market by Country 2016-2021
8.1.1 Europe Antivenom Sales by Country
8.1.2 Europe Antivenom Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Antivenom Market by Country 2016-2021
9.1.1 Asia Pacific Antivenom Sales by Country
9.1.2 Asia Pacific Antivenom Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Antivenom Market by Country 2016-2021
10.1.1 South America Antivenom Sales by Country
10.1.2 South America Antivenom Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Antivenom Market by Country 2016-2021
11.1.1 Middle East and Africa Antivenom Sales by Country
11.1.2 Middle East and Africa Antivenom Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 CSL
12.1.1 CSL Company Information
12.1.2 CSL Antivenom Product Portfolio, Specification and Application
12.1.3 CSL Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 CSL Key Development
12.2 Vins Bioproducts
12.2.1 Vins Bioproducts Company Information
12.2.2 Vins Bioproducts Antivenom Product Portfolio, Specification and Application
12.2.3 Vins Bioproducts Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Vins Bioproducts Key Development
12.3 Serum Biotech
12.3.1 Serum Biotech Company Information
12.3.2 Serum Biotech Antivenom Product Portfolio, Specification and Application
12.3.3 Serum Biotech Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Serum Biotech Key Development
12.4 Rare Disease Therapeutics
12.4.1 Rare Disease Therapeutics Company Information
12.4.2 Rare Disease Therapeutics Antivenom Product Portfolio, Specification and Application
12.4.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Rare Disease Therapeutics Key Development
12.5 Pfizer
12.5.1 Pfizer Company Information
12.5.2 Pfizer Antivenom Product Portfolio, Specification and Application
12.5.3 Pfizer Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Pfizer Key Development
12.6 MicroPharm
12.6.1 MicroPharm Company Information
12.6.2 MicroPharm Antivenom Product Portfolio, Specification and Application
12.6.3 MicroPharm Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 MicroPharm Key Development
12.7 Merck
12.7.1 Merck Company Information
12.7.2 Merck Antivenom Product Portfolio, Specification and Application
12.7.3 Merck Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 MicroPharm Key Development
12.9 Flynn Pharma
12.9.1 Flynn Pharma Company Information
12.9.2 Flynn Pharma Antivenom Product Portfolio, Specification and Application
12.9.3 Flynn Pharma Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Flynn Pharma Key Development
12.8 Haffkine Bio-Pharmaceutical
12.8.1 Haffkine Bio-Pharmaceutical Company Information
12.8.2 Haffkine Bio-Pharmaceutical Antivenom Product Portfolio, Specification and Application
12.8.3 Haffkine Bio-Pharmaceutical Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Haffkine Bio-Pharmaceutical Key Development
12.11 Bharat Serums and Vaccines
12.11.1 Bharat Serums and Vaccines Company Information
12.11.2 Bharat Serums and Vaccines Antivenom Product Portfolio, Specification and Application
12.11.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Bharat Serums and Vaccines Key Development

13 Global Antivenom Market Forecast by Region by Type and by Application
13.1 Global Antivenom Sales, Revenue Forecast 2022-2027
13.2 Global Antivenom Forecast by Regions
13.2.1 Global Antivenom Sales Forecast by Region 2022-2027
13.2.2 Global Antivenom Revenue Forecast by Region 2022-2027
13.3 Global Antivenom Forecast by Type
13.3.1 Global Antivenom Sales Forecast by Type 2022-2027
13.3.2 Global Antivenom Revenue Forecast by Type 2022-2027
13.3.3 Global Antivenom Price Forecast by Type 2022-2027
13.4 Global Antivenom Forecast by Application
13.4.1 Global Antivenom Sales Forecast by Application 2022-2027
13.4.2 Global Antivenom Revenue Forecast by Application 2022-2027
13.4.3 Global Antivenom Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Antivenom Production Specifications
Table 2: Drivers in Antivenom Market
Table 3: Restraints Antivenom Market
Table 4: Opportunity in Antivenom Market
Table 5: Comparion of Alternative and Antivenom
Table 6: Antivenom Raw Materials Key Suppliers List
Table 7: Antivenom Distributors List
Table 8: Antivenom Major Buyers in Application One
Table 9: Antivenom Major Buyers in Application Two
Table 10: Antivenom Major Buyers in Application Three
Table 11: Global Antivenom Sales (K Units) by Type 2016-2021
Table 12: Global Antivenom Sales Market Share by Type 2016-2021
Table 13: Global Antivenom Revenue (Million USD) by Type 2016-2021
Table 14: Global Antivenom Revenue Market Share by Type 2016-2021
Table 15: Global Antivenom Price by Type 2016-2021
Table 16: Global Antivenom Sales (K Units) by Application 2016-2021
Table 17: Global Antivenom Sales Market Share by Application 2016-2021
Table 18: Global Antivenom Revenue (Million USD) by Application 2016-2021
Table 19: Global Antivenom Revenue Market Share by Application 2016-2021
Table 20: Global Antivenom Price by Application 2016-2021
Table 21: Global Antivenom Sales (K Units) by Region 2016-2021
Table 22: Global Antivenom Sales Market Share by Region 2016-2021
Table 23: Global Antivenom Revenue (Million USD) by Region 2016-2021
Table 24: Global Antivenom Revenue Market Share by Region 2016-2021
Table 25: North America Antivenom Sales (K Units) by Country 2016-2021
Table 26: North America Antivenom Sales Market Share by Country 2016-2021
Table 27: North America Antivenom Revenue (Million USD) by Country 2016-2021
Table 28: North America Antivenom Revenue Market Share by Country 2016-2021)
Table 29: Europe Antivenom Sales (K Units) by Country 2016-2021
Table 30: Europe Antivenom Sales Market Share by Country 2016-2021
Table 31: Europe Antivenom Revenue (Million USD) by Country 2016-2021
Table 32: Europe Antivenom Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Antivenom Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Antivenom Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Antivenom Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Antivenom Revenue Market Share by Country 2016-2021)
Table 37: South America Antivenom Sales (K Units) by Country 2016-2021
Table 38: South America Antivenom Sales Market Share by Country 2016-2021
Table 39: South America Antivenom Revenue (Million USD) by Country 2016-2021
Table 40: South America Antivenom Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Antivenom Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Antivenom Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Antivenom Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Antivenom Revenue Market Share by Country 2016-2021)
Table 45 CSL Company Information
Table 46 CSL Antivenom Product Portfolio, Specification and Application
Table 47 CSL Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Vins Bioproducts Company Information
Table 49 Vins Bioproducts Antivenom Product Portfolio, Specification and Application
Table 50 Vins Bioproducts Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Serum Biotech Company Information
Table 52 Serum Biotech Antivenom Product Portfolio, Specification and Application
Table 53 Serum Biotech Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Rare Disease Therapeutics Company Information
Table 55 Rare Disease Therapeutics Antivenom Product Portfolio, Specification and Application
Table 56 Rare Disease Therapeutics Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Pfizer Company Information
Table 58 Pfizer Antivenom Product Portfolio, Specification and Application
Table 59 Pfizer Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 MicroPharm Company Information
Table 61 MicroPharm Antivenom Product Portfolio, Specification and Application
Table 62 MicroPharm Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Merck Company Information
Table 64 Merck Antivenom Product Portfolio, Specification and Application
Table 65 Merck Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Haffkine Bio-Pharmaceutical Company Information
Table 67 Haffkine Bio-Pharmaceutical Antivenom Product Portfolio, Specification and Application
Table 68 Haffkine Bio-Pharmaceutical Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Flynn Pharma Company Information
Table 70 Flynn Pharma Antivenom Product Portfolio, Specification and Application
Table 71 Flynn Pharma Antivenom Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Antivenom Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Antivenom Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Antivenom Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Antivenom Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Antivenom Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Antivenom Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Antivenom Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Antivenom Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Antivenom Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Antivenom Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Antivenom Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Antivenom Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Antivenom Picture
Figure 2: Global Antivenom Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Antivenom Supply Chain Analysis
Figure 5: Antivenom Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Polyvalent antivenom
Figure 7: Product Picture of Monovalent antivenom
Figure 8: Global Antivenom Sales Market Share by Type, 2020
Figure 9: Global Antivenom Revenue Market Share by Type, 2020
Figure 10: Antivenom in Non-profit Institutions
Figure 11: Global Antivenom Market: Non-profit Institutions 2016-2021
Figure 12: Antivenom in Hospitals and Clinic
Figure 13: Global Antivenom Market: Hospitals and Clinic 2016-2021
Figure 14: Global Antivenom Sales Market Share by Application, 2020
Figure 15: Global Antivenom Revenue Market Share by Application, 2020
Figure 16: Global Antivenom Sales Market Share by Region 2016-2021
Figure 17: Global Antivenom Revenue Market Share by Region 2016-2021
Figure 18: North America Antivenom Sales (K Units) Status 2016-2021
Figure 19: North America Antivenom Revenue (Million USD) Status 2016-2021
Figure 20: Europe Antivenom Sales (K Units) Status 2016-2021
Figure 21: Europe Antivenom Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Antivenom Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Antivenom Revenue (Million USD) Status 2016-2021
Figure 24: South America Antivenom Sales (K Units) Status 2016-2021
Figure 25: South America Antivenom Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Antivenom Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Antivenom Revenue (Million USD) Status 2016-2021
Figure 28: North America Antivenom Sales Market Share by Country, 2020
Figure 29: North America Antivenom Revenue Market Share by Country, 2020
Figure 30: United States Antivenom Sales (K Units) Status 2016-2021
Figure 31: United States Antivenom Revenue (Million USD) Status 2016-2021
Figure 32: Canada Antivenom Sales (K Units) Status 2016-2021
Figure 33: Canada Antivenom Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Antivenom Sales (K Units) Status 2016-2021
Figure 35: Mexico Antivenom Revenue (Million USD) Status 2016-2021
Figure 36: Europe Antivenom Sales Market Share by Country, 2020
Figure 37: Europe Antivenom Revenue Market Share by Country, 2020
Figure 38: Germany Antivenom Sales (K Units) Status 2016-2021
Figure 39: Germany Antivenom Revenue (Million USD) Status 2016-2021
Figure 40: France Antivenom Sales (K Units) Status 2016-2021
Figure 41: France Antivenom Revenue (Million USD) Status 2016-2021
Figure 42: UK Antivenom Sales (K Units) Status 2016-2021
Figure 43: UK Antivenom Revenue (Million USD) Status 2016-2021
Figure 44: Italy Antivenom Sales (K Units) Status 2016-2021
Figure 45: Italy Antivenom Revenue (Million USD) Status 2016-2021
Figure 46: Russia Antivenom Sales (K Units) Status 2016-2021
Figure 46: Russia Antivenom Revenue (Million USD) Status 2016-2021
Figure 47: Spain Antivenom Sales (K Units) Status 2016-2021
Figure 48: Spain Antivenom Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Antivenom Sales Market Share by Country, 2020
Figure 50: Asia Pacific Antivenom Revenue Market Share by Country, 2020
Figure 51: China Antivenom Sales (K Units) Status 2016-2021
Figure 52: China Antivenom Revenue (Million USD) Status 2016-2021
Figure 53: Japan Antivenom Sales (K Units) Status 2016-2021
Figure 54: Japan Antivenom Revenue (Million USD) Status 2016-2021
Figure 55: Korea Antivenom Sales (K Units) Status 2016-2021
Figure 56: Korea Antivenom Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Antivenom Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Antivenom Revenue (Million USD) Status 2016-2021
Figure 59: India Antivenom Sales (K Units) Status 2016-2021
Figure 60: India Antivenom Revenue (Million USD) Status 2016-2021
Figure 61: Australia Antivenom Sales (K Units) Status 2016-2021
Figure 62: Australia Antivenom Revenue (Million USD) Status 2016-2021
Figure 63: South America Antivenom Sales Market Share by Country, 2020
Figure 64: South America Antivenom Revenue Market Share by Country, 2020
Figure 65: Brazil Antivenom Sales (K Units) Status 2016-2021
Figure 66: Brazil Antivenom Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Antivenom Sales (K Units) Status 2016-2021
Figure 68: Argentina Antivenom Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Antivenom Sales (K Units) Status 2016-2021
Figure 70: Colombia Antivenom Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Antivenom Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Antivenom Revenue Market Share by Country, 2020
Figure 73: Turkey Antivenom Sales (K Units) Status 2016-2021
Figure 74: Turkey Antivenom Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Antivenom Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Antivenom Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Antivenom Sales (K Units) Status 2016-2021
Figure 78: South Africa Antivenom Revenue (Million USD) Status 2016-2021
Figure 79: CSL Antivenom Revenue Market Share Globally (2019-2021)
Figure 80: Vins Bioproducts Antivenom Revenue Market Share Globally (2019-2021)
Figure 81: Serum Biotech Antivenom Revenue Market Share Globally (2019-2021)
Figure 82: Rare Disease Therapeutics Antivenom Revenue Market Share Globally (2019-2021)
Figure 83: Pfizer Antivenom Revenue Market Share Globally (2019-2021)
Figure 84: MicroPharm Antivenom Revenue Market Share Globally (2019-2021)
Figure 85: Merck Antivenom Revenue Market Share Globally (2019-2021)
Figure 86: Haffkine Bio-Pharmaceutical Antivenom Revenue Market Share Globally (2019-2021)
Figure 87: Flynn Pharma Antivenom Revenue Market Share Globally (2019-2021)
Figure 88: BTG Antivenom Revenue Market Share Globally (2019-2021)
Figure 89: Global Antivenom Sales (K Units) Forecast (2022-2027)
Figure 90: Global Antivenom Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets